Your Search Results

AICT-AsiaPCR 2024 Opening ceremony

04 Oct 2024 – From AICT-AsiaPCR 2024

In the AICT-AsiaPCR 2024 opening ceremony, discover the key figures, explore the programme, and learn about the national societies and working groups involved. Highlights include the Chien Foundation Lifetime Achievement Award in cardiovascular intervention, the nomination of the APSIC Fellows 2024, and insights into Asia Intervention...

AICT-AsiaPCR 2024 Awards ceremony

05 Oct 2024 – From AICT-AsiaPCR 2024

Join us for this exciting awards ceremony, where you'll first meet the three winners selected from 322 candidates across 27 countries who received accolades for the best clinical cases. Witness the presentation of the award-winning case titled 'Percutaneous Intervention of Stuck Prosthetic Mitral Valve'. Following that,...

AICT-AsiaPCR 2024 Closing ceremony

05 Oct 2024 – From AICT-AsiaPCR 2024

As the 2024 edition of AICT-AsiaPCR comes to a close, this special ceremony offers a moment to thank everyone who contributed to its success. It’s a chance to reflect on the highlights and achievements of the event, supported by memorable images, while also offering a preview...

Absolute coronary flow and microvascular resistance before and after transcatheter aortic valve implantation

12 Nov 2024

This study aims to evaluate changes in microcirculatory function post-TAVI, specifically assessing resting and hyperaemic absolute coronary flow and microvascular resistance before TAVI, immediately post, and at 6-month follow-up.

Reviewer

Christian Said

Reviewer

Nicola Ryan

Absolute coronary flow and microvascular resistance before and after TAVI

Latest advances in interventional cardiology: Top abstracts on TAVI, PCI, and mitral valve repair

04 Oct 2024 – From AICT-AsiaPCR 2024

Discover the cutting-edge research and innovative solutions presented in the 'Best Abstracts of AICT-AsiaPCR 2024' session. This curated selection showcases the latest advancements in interventional cardiology, from groundbreaking comparisons of transcatheter mitral valve repair techniques to the impact of cerebral embolic protection devices in TAVI procedures....

Latest advances in interventional cardiology: Top abstracts on TAVI, PCI, and mitral valve repair

GulfPCR-GIM 2024 - Training Programme

Take a look at the Training Programme for this new edition edition of GulfPCR-GIM 2024, taking place on 18-19 December 2024

How should I treat a torrential tricuspid valve regurgitation with large coaptation gap size and severe tethered leaflets?

26 Nov 2024

An 84-year-old female patient with severe tricuspid valve regurgitation (TR) and progressive right-sided heart failure signs is referred for diagnosis and treatment. Transoesophageal echocardiography (TEE) reveals isolated torrential TR (5/5) with a large coaptation gap size and tethered leaflets. How would you treat this patient?

Author

Rico Osteresch

How should I treat a torrential tricuspid valve regurgitation with large coaptation gap size and severe tethered leaflets?

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

Focus on drug coated balloons: evidence and practice

07 Jan 2025

This Special Report led by Andreas Baumbach explores the history, current techniques, evidence, and future of DCBs, plus insights on left main stent restenosis.

Evidence base: A description of the key, so far published, studies in the space of drug coated balloons

23 Jan 2025

Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.